As the market grinds down toward the end of the summer, we’re seeing the typical seasonal malaise when a number of good companies quietly drift down to 52-week lows. And the selling may not be over. The S&P 500 has historically been the weakest in September, dropping an average of -1.3%. The good news: stocks really build a head of steam after that. The S&P 500 typically rises +0.7% in October, followed by average monthly gains of +1.5%, +1.9% and +2.1% in each of the next three months. Savvy investors always keep some cash on hand for… Read More
As the market grinds down toward the end of the summer, we’re seeing the typical seasonal malaise when a number of good companies quietly drift down to 52-week lows. And the selling may not be over. The S&P 500 has historically been the weakest in September, dropping an average of -1.3%. The good news: stocks really build a head of steam after that. The S&P 500 typically rises +0.7% in October, followed by average monthly gains of +1.5%, +1.9% and +2.1% in each of the next three months. Savvy investors always keep some cash on hand for these summer doldrums, as it can be a fertile time to start researching unloved stocks that should find new appreciation as summer turns to fall. Here are four names hitting new 52-week lows on Friday that should be quite appealing for long-term investors. MedcoHealth Solutions (NYSE: MHS) Earlier this summer, we saw a considerable dust-up between CVS (NYSE: CVS) and Walgreen (NYSE: WAG) as those two firms fought over a pharmacy benefits manager (PBM) contract. As we looked into the PBM sector in June, we saw still-considerable growth prospects,… Read More